Skip to main content
. 2014 Jan 9;3:19. doi: 10.4103/2277-9175.124650

Figure 2.

Figure 2

Characterization of BMD-MSCs. (a) Morphological evaluation of BMD-MSCs in passage five. (b) Representative FACS analysis shows that BMD-MSCs are negative for hematopoietic markers (CD34 and CD45), but are positive for MSC markers (Stro-1 and CD73). Black-filled histogram shows isotype control antibody and red histograms show CD34, CD45, Stro-1, or CD73 antigens